Indofarma Tbk.
Hub Segmentasi: Analisis Fundamental Umum (General Hub)
Tingkat pengembalian modal yang diinvestasikan. Nilai > 12% menunjukkan alokasi modal...
Mendeteksi kualitas laba bersih. Rasio di luar rentang -10% s/d 10% mengindikasikan l...
Rasio total utang terhadap modal ekuitas bersih.
Diagnosis Kesimpulan Sektor
Kinerja fundamental stabil, namun perhatikan tingkat margin laba bersih operasional dan rasio utang ekuitas.
Emiten teratas dalam sektor Healthcare
PT Indofarma Tbk, together with its subsidiaries, manufactures and sells pharmaceutical products in Indonesia and internationally. The company offers laboratory, pharmaceutical, and health glass equipment; orthopedic and prosthetic equipment; medical and dental equipment; and reparation of Irradiation / X-ray, electromedical and electrotherapy equipment. It also trades in laboratory, pharmaceutical, and medical equipment; and engages in herb infusion, health support, private polyclinic, general practitioner, dentist, and internet trading applications activities. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is based in Bekasi, Indonesia. The company operates as a subsidiary of PT Bio Farma.
Beginner Insight:Understanding the "Architecture" helps you verify the company's physical scale and legitimacy. A global workforce usually indicates a mature, institutional player.